2. Others

Others

Others

Related Products

PDF 58.49 MB

There are a number of inhibitors, agonists, and antagonists which we cannot make precise classification because the research area is still unknown.

Others Related Products (73911):

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-121783
    BE2254 40077-13-2 98%
    BE2254 is a compound with antipyretic and metabolic activity, which has the activity of regulating the febrile response and metabolism. BE2254 can reduce the metabolic and febrile activity induced by lipopolysaccharide in febrile rabbits, suggesting that it may regulate body temperature by acting on the α1-adrenergic receptor mechanism.
    BE2254
  • HY-121787
    OX1a 136340-88-0 98%
    OX1a (OLC20) is an Orco antagonist with non-competitive activity that inhibits the activation of oxygen odor receptors (ORs). OX1a is able to reduce the activation of ORs by competitively inhibiting the effects of Orco agonists. OX1a also shows non-competitive inhibition of odor molecules, which may affect the olfactory-mediated behavior of insects. Through structural optimization, OX1a analogs have shown higher antagonistic potency, indicating that this type of compound may have application potential in a wide range of insect species.
    OX1a
  • HY-121789
    Proadifen 302-33-0
    Proadifen is a compound that inhibits cytochrome P450 activity, which can change the excitability of catecholamine-secreting neurons in the brain and have different effects on neurons in different brain regions.
    Proadifen
  • HY-121789S
    Proadifen-d2 151412-33-8 98%
    Proadifen-d2 is the deuterium labeled Proadifen (HY-121789).
    Proadifen-d2
  • HY-121791S
    Fluometuron-d6 2030182-29-5 98%
    Fluometuron-d6 is the deuterium labeled Fluometuron.
    Fluometuron-d6
  • HY-121792
    CK2-IN-1 51726-83-1 98%
    CK2-IN-1 is a CK2 inhibitor, with an IC50 of 150 nM.
    CK2-IN-1
  • HY-121796
    Mixanpril 156039-69-9 98%
    Mixanpril is a compound with the ability to modulate insulin sensitivity and has the activity of regulating insulin sensitivity and femoral blood flow in obese Zucker rats. Mixanpril can affect insulin-mediated glucose disposal in obese Zucker rats and also has a regulatory effect on femoral blood flow, with different effects compared to the ACE inhibitor captopril.
    Mixanpril
  • HY-121799S
    Taurohyocholic acid-d4 sodium 98%
    Taurohyocholic acid-d4 (sodium) is the deuterium labeled Taurohyocholic acid sodium.
    Taurohyocholic acid-d4 sodium
  • HY-121800
    ML138 1355243-24-1 98%
    ML138, a κ opioid receptor agonist, is a MLPCN probe.
    ML138
  • HY-121804
    SSJ-183 1187533-34-1 98%
    SSJ-183 is a compound with antimalarial activity, with activity that modulates antimalarial effects and pharmacokinetic properties. SSJ-183 has shown some activity in antimalarial studies, and its pharmacokinetic properties are between those of other tested compounds, which is of certain significance for the study of new antimalarial combination therapies.
    SSJ-183
  • HY-121814
    (S)-Acenocoumarol 66556-78-3 98%
    (S)-Acenocoumarol is an active compound.
    (S)-Acenocoumarol
  • HY-121855
    1-Monoelaidin 2716-53-2 98%
    Monoeladin is an ester derivative of glycerin and oleic acid, which are commonly found in various vegetable and animal fats. Monoeladin has unique chemical properties that make it an important intermediate in the biosynthesis of other lipid molecules, especially in the formation of triglycerides and phospholipids. It also plays a role in food science as a partial replacement for saturated fat, which has been linked to an increased risk of heart disease.
    1-Monoelaidin
  • HY-121867
    KSCM-11 1415247-16-3 98%
    KSCM-11 is a ligand of thesigma receptor.
    KSCM-11
  • HY-121880
    Difenoxuron 14214-32-5 98%
    Difenoxuron is an active compound.
    Difenoxuron
  • HY-121899
    1-Oxo Ibuprofen 65813-55-0 98%
    1-Oxo Ibuprofen (Ibuprofen EP impurity J) is a degradation product and a potential impurity in preparations of Ibuprofen. Ibuprofen is an anti-inflammatory inhibitor targeting COX-1 and COX-2 with IC50s of 13 μM and 370 μM, respectively.
    1-Oxo Ibuprofen
  • HY-121902
    Butidrine 7433-10-5 98%
    Butidrine is a compound with intraocular pressure-lowering activity that is less effective than some other beta-adrenergic receptor blockers in reducing intraocular pressure in rabbit eyes.
    Butidrine
  • HY-121914S
    (2-Chlorophenyl)diphenyl-methanol-d5 1219802-30-8 98%
    (2-Chlorophenyl)diphenyl-methanol-d5 is the deuterium labeled (2-Chlorophenyl)diphenylmethanol.
    (2-Chlorophenyl)diphenyl-methanol-d5
  • HY-121918
    RU 41656 134377-22-3 98%
    RU 41656 partially alleviated triazolam-induced memory impairment but did not counteract the sedative effects of this agent.
    RU 41656
  • HY-12193
    A-349821 556835-30-4 98%
    A-349821 is a histamine H3 receptor antagonist characterized as a radioligand ([3H]-A-349821) for in vivo receptor occupancy assessment. In rats, [3H]-A-349821 penetrated the brain, showing higher levels in the cortex compared to the cerebellum, indicating selective H3 receptor binding. Its cortical occupancy was saturable, correlating with in vitro binding data. Inhibition studies with ABT-239 and other H3 antagonists showed dose-dependent reductions in receptor occupancy, matching blood levels associated with cognitive efficacy in preclinical models. [3H]-A-349821 thus serves as a valid tracer for H3 receptor occupancy, aiding in the development and clinical interpretation of H3 receptor antagonists.
    A-349821
  • HY-121939R
    6-Hydroxy-L-DOPA (Standard) 27244-64-0
    6-Hydroxy-L-DOPA (Standard) is the analytical standard of 6-Hydroxy-L-DOPA. This product is intended for research and analytical applications. 6-Hydroxy-L-DOPA is a nucleic acid functionalized with electron-donating units.
    6-Hydroxy-L-DOPA (Standard)